Concepedia

Regulatory Genotoxicity Testing

Regulatory Genotoxicity Testing is a standardized biological assessment protocol belonging to the class of genotoxicity testing methods, distinguished by its formal validation and acceptance by regulatory authorities for evaluating the potential of chemical substances to cause genetic damage as part of pre-market safety evaluation.

114

Publications

7.7K

Citations

514

Authors

189

Institutions

Publications per year

2017–2026

24

Parents

Publications

114

Recommendations for conducting the in vivo alkaline Comet assay

Andreas Hartmann · Mutagenesis · 2002 · 1.1K citations · Full text

, , +17

Opinion of the Scientific Committee on a request from EFSA related to A Harmonised Approach for Risk Assessment of Substances Which are both Genotoxic and Carcinogenic

EFSA Journal · 2005 · 568 citations · Full text

, , +15

Scientific opinion on genotoxicity testing strategies applicable to food and feed safety assessment

EFSA Journal · 2011 · 470 citations · Full text

, , +13

The BlueScreen HC assay to predict the genotoxic potential of fragrance materials

Yax Thakkar, Kaushal Joshi, Christina Hickey et al. · Mutagenesis · 2022 · 399 citations · Full text

, , +16

In vivo rodent erythrocyte micronucleus assay. II. Some aspects of protocol design including repeated treatments, integration with toxicity testing, and automated scoring

Makoto Hayashi, James T. MacGregor, D. Gatehouse et al. · Environmental and Molecular Mutagenesis · 2000 · 241 citations

, , +16

1–5 of 114

Authors

514

  1. DK
    David Kirkland

    Covance (United Kingdom), United Kingdom

    8 publications · 532 citations

    8

    h-index

  2. SP
    Stefan Pfuhler

    Procter & Gamble (United States), United States

    7 publications · 776 citations

    7

    h-index

  3. JT
    James T. MacGregor

    Western Regional Research Center, United States

    7 publications · 517 citations

    7

    h-index

  4. MH
    Makoto Hayashi

    National Institute of Health Sciences, Japan

    7 publications · 589 citations

    7

    h-index

  5. PK
    Peter Kasper

    Federal Institute for Drugs and Medical Devices, Germany

    7 publications · 416 citations

    7

    h-index

1–5 of 514

Institutions

189

  1. National Institute of Health Sciences

    Tokyo, Japan

    12 h-index

    16 publications

    950 citations

  2. United States Food and Drug Administration

    Silver Spring, United States

    11 h-index

    25 publications

    1.2K citations

  3. Federal Institute for Drugs and Medical Devices

    Bonn, Germany

    11 h-index

    13 publications

    777 citations

  4. Covance (United Kingdom)

    Harrogate, United Kingdom

    9 h-index

    19 publications

    897 citations

  5. Health Canada

    Ottawa, Canada

    8 h-index

    12 publications

    611 citations

  6. GlaxoSmithKline (United Kingdom)

    London, United Kingdom

    8 h-index

    10 publications

    519 citations

  7. Procter & Gamble (United States)

    Cincinnati, United States

    7 h-index

    8 publications

    858 citations

  8. Roche (Switzerland)

    Basel, Switzerland

    7 h-index

    17 publications

    752 citations

1–8 of 189

Venues

  1. 18

    h-index

  2. Mutagenesis

    18 publications · 2.2K citations

    16

    h-index

  3. Environmental and Molecular Mutagenesis

    13 publications · 619 citations

    12

    h-index

  4. EFSA Journal

    9 publications · 1.4K citations

    9

    h-index

  5. Regulatory Toxicology and Pharmacology

    RTP · 5 publications · 247 citations

    5

    h-index

1–5